Neuromodulation Market Analysis by Industry Perspective, Comprehensive Analysis Growth and Forecast 2020-2027

The Neuromodulation market was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3%during 2020-2027.

The growth of the neuromodulation market is driven by the factors such as increasing incidence of neurological disorders and growing developments in neuromodulation technology. Further, the rising demand of neurostimulation devices to treat chronic pain offer lucrative opportunities to the global neuromodulation market players. However, the high cost of neuromodulation devices hinders the market growth.

Get Sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPHE100001415/?utm_source=OpenPR&utm_medium=10188

Some of the Major Market Players Are:

These companies focus on partnerships, product launches, and collaborations, among other business strategies, to sustain their market positions. For instance, in September 2020, Boston Scientific announced its WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems for the European market. The portfolio comprises four MRI conditional and Bluetooth-enabled implantable pulse generators (IPGs). The products from this line feature rechargeable and non-rechargeable options, and an access to waveforms that help cover multiple pain areas.

On the basis of technology, the neuromodulation market is bifurcated into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for a larger share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in neuromodulation devices.

Have a 15-minute long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well: https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001415/?utm_source=OpenPR&utm_medium=10188

The report segments the global neuromodulation market as follows:

By Technology

• External (Non-Invasive) Neuromodulation
o Respiratory Electrical Stimulation
o Transcutaneous Electrical Nerve Stimulation
o Transcranial Magnetic Stimulation
• Internal Neuromodulation
o Deep Brain Stimulation
o Sacral Nerve Stimulation
o Gastric Electrical Stimulation
o Spinal Cord Stimulation
o Vagus Nerve Stimulation

By Application

• Chronic Pain Management
• Failed Back Syndrome
• Epilepsy
• Tremor
• Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease
• Obsessive-Compulsive Disorder
• Migraine

By End User

• Hospitals
• Clinics
• Home Healthcare

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPHE100001415/?utm_source=OpenPR&utm_medium=10188

Contact Us:

If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.